The DA welcomes the arrival of the first doses of Lenacapavir donated by the Global Fund in South Africa. Lenacapavir is an injection given to HIV-negative individuals once every six months as pre-exposure prophylaxis medicine (PrEP) to prevent infection.
South Africa has one of the largest HIV-positive populations in the world – an estimated 8.15 million people in South Africa are living with HIV. More than 6.2 million people rely on antiretroviral therapy (ART) to stay alive. Lenacapavir could be a game changer in South Africa’s fight against HIV/Aids and prevent countless future infections.
The DA will request that the Minister of Health, Dr Aaron Motsoaledi, present the parliamentary portfolio committee with a full roll-out plan and timeline, as well as progress on implementation.